Perspective Therapeutics, Inc. (CATX) income statement
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics, Inc. financial ratios
See a number that looks wrong?